No profile data available.
Irwin Naturals, Inc. (IWINQ) is an essential consumer products company in the medication retail outlets industry, based in Los Angeles, United States.
It reported revenue of $89.47 million for fiscal year 2022, down 10.8% from fiscal year 2021, and net income of -$3.99 million. In Q3 2023 (the quarter ended September 30, 2023) revenue was $19.07 million, down 13.4% from a year before. Its market capitalization was $736,487 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2022; market data as of October 8, 2026.
Irwin Naturals, Inc. engages in the development and distribution of vitamins and other health supplements in the United States, Canada, and internationally. The company offers CBD oils, gummies, soft gels, CBD creams, balms and roll-ons, vitamins and supplements, topicals, and other products. It also operates mental health clinics.
Irwin Naturals reported $89.47 million in revenue for fiscal year 2022, down 10.8% from $100.34 million in fiscal year 2021. In Q3 2023 revenue was $19.07 million.
$736,487 as of October 8, 2026.
Listed companies of a similar size in the same industry (medication retail outlets) include Polomar Health Services, Inc. (PMHS), Cellyan Biotechnology Co., Ltd (HKPD), Relevium Technologies Inc. (RLLVF), Allstar Health Brands, Inc. (ALST).